+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Paratek Pharmaceuticals - logo

Paratek Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of therapeutics based upon tetracycline chemistry. Its lead product candidates include Omadacycline and Sarecycline, both of which are undergoing clinical trials. It has collaborative research and license agreement with Allergan plc to research and develop tetracycline products. Paratek was incorporated in 2001 and is based in Boston, Massachusetts.

From
From
Acute Pyelonephritis - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Pyelonephritis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Acne Vulgaris - Pipeline Review, H2 2020 - Product Thumbnail Image

Acne Vulgaris - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 217 Pages
  • Global
From
Multidrug Resistant Bacteria Global Market Report 2024 - Product Thumbnail Image

Multidrug Resistant Bacteria Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Nontuberculous Mycobacterial Infection Global Market Report 2024 - Product Thumbnail Image

Nontuberculous Mycobacterial Infection Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
Plague - Pipeline Insight, 2024 - Product Thumbnail Image

Plague - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Anthrax - Pipeline Insight, 2024 - Product Thumbnail Image

Anthrax - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
mTOR Inhibitors Global Market Report 2024 - Product Thumbnail Image

mTOR Inhibitors Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Loading Indicator